AA
DXCM icon

AlphaCentric Advisors’s DexCom DXCM Stock Holding History

AlphaCentric Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,171
Closed -$280K – 228
2024
Q3 		$280K Buy
+4,171
New +$343K 0.21% 113

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

AlphaCentric Advisors's DXCM Position: Q4 2024 in Review

AlphaCentric Advisors sold out of DexCom (DXCM) in Q4 2024, closing a stake of 4,171 shares — an estimated $280K sold.

AlphaCentric Advisors first reported a position in DXCM in Q3 2024 and held it in 1 quarter. The position peaked at $280K in Q3 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • AlphaCentric Advisors reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • AlphaCentric Advisors sold 4,171 DexCom shares in Q4 2024, an estimated $280K.
  • AlphaCentric Advisors first reported a position in DexCom in Q3 2024 and held it in 1 quarter.
  • AlphaCentric Advisors's DexCom position peaked at $280K in Q3 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.